During the last session, Nurix Therapeutics Inc (NASDAQ:NRIX)’s traded shares were 0.6 million, with the beta value of the company hitting 2.09. The 52-week high for the NRIX share is $18.12, that puts it down -46.6 from that peak though still a striking 65.86% gain since the share price plummeted to a 52-week low of $4.22. The company’s market capitalization is $733.20M, and the average trade volume was 1.01 million shares over the past three months.
Nurix Therapeutics Inc (NASDAQ:NRIX) trade information
The stock’s 5-day price performance is -9.05%, and it has moved by -14.99% in 30 days. Based on these gigs, the overall price performance for the year is 19.19%.
Nurix Therapeutics Inc (NRIX) estimates and forecasts
Statistics show that Nurix Therapeutics Inc has underperformed its competitors in share price, compared to the industry in which it operates. Nurix Therapeutics Inc (NRIX) shares have gone up 190.82% during the last six months, with a year-to-date growth rate less than the industry average at -18.87% against 12.90. In the rating firms’ projections, revenue will decrease -3.60% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 23.44M as predicted by 7 analyst(s). Meanwhile, a consensus of 7 analyst(s) estimates revenue growth to 17.88M by the end of current fiscal year.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -59.00%. While earnings are projected to return -11.80% in 2024.
NRIX Dividends
Nurix Therapeutics Inc is due to release its next quarterly earnings in May. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
